Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centraal Diergeneskundig InstitutfiledCriticalCentraal Diergeneskundig Institut
Priority to RO121081ApriorityCriticalpatent/RO96364B1/ro
Publication of RO96364B1publicationCriticalpatent/RO96364B1/ro
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents
(AREA)
Abstract
Inventia se refera la un procedeu de preparare a unui vaccin viu, purificat, împotriva bolii lui Mrec, cuprinzând obtinerea unei clone a virusului bolii lui Marek prin supunerea tulpinii MDV CVI-988 unor pasaje succesive în culturi celulare aviare si transformarea acesteia în vaccin prin amestecarea cu materiale auxiliare adecvate. Procedeul permite obtinerea unei clone virale, care, în comparatie cu tuplina-mama, prezinta imunogenitate si patogenitate reduse, în special fata de puii Rhode Island Red, foarte susceptibili la boala lui Marek si apoi, obtinerea cu ajutorul clonei a unui vaccin eficient împotriva bolii lui Marek.
RO121081A1985-12-091985-12-09PROCEDEU DE PREPARARE A UNUI VACCIN VIU PURIFICAT îMPOTRIVA BOLII LUI MAREK
RO96364B1
(ro)
Peptid-zusammensetzung fuer die herstellung von malaria-impfstoff, sowie fuer die vorbereitung von diagnostischen einzelteilen fuer den nachweis von malaria-aehnlichen krankheiten.
Peptides capable of being recognized by antibodies induced against human immunodeficiency retrovirus(hiv-virus),their applications for diagnosis of infections caused by some of these viruses and,in case,to vaccination against aids
Antigens relating to envelope glyoprotein of the virus of aids, particularly precursors of this glycoprotein, methods of obtaining these antigens and means employed in these methods, applications of these antigens in the preparation of immunogenic compositions or for the diagnosis of aids or